# tofacitinib solution

NDC: 0054-0821
Generic name: tofacitinib
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20260603

FDA application: ANDA216878

## Active ingredients

- TOFACITINIB CITRATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0821"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0821
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9cf18a9-e825-49ac-b080-68957c0e79ae